BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20637505)

  • 1. A child with myeloid/natural killer cell precursor acute leukemia treated successfully with acute myeloid leukemia-oriented chemotherapy incorporating L-asparaginase.
    Morimoto M; Kondoh K; Keino D; Ohyama R; Ban S; Kinoshita A; Kitoh T
    Leuk Res; 2010 Dec; 34(12):1677-9. PubMed ID: 20637505
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation.
    Tezuka K; Nakayama H; Honda K; Suzumiya J; Oshima K; Kitoh T; Ishii E
    Int J Hematol; 2002 Feb; 75(2):201-6. PubMed ID: 11939270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
    Guan XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang YC; Luo XQ
    Pediatr Hematol Oncol; 2011 Apr; 28(3):187-93. PubMed ID: 21271777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL).
    Garcia-Manero G; Kantarjian HM; Kornblau S; Estey E
    Leukemia; 2002 Sep; 16(9):1888. PubMed ID: 12200720
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective combination treatment of advanced acute lymphocytic leukemia with cytosine arabinoside (NSC-63878) and L-asparaginase (NSC-109229).
    Ortega JA; Finklestein JZ; Ertel I; Hammond D; Karon M
    Cancer Chemother Rep; 1972 Jun; 56(3):363-8. PubMed ID: 19051496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retherapy using L-asparaginase with octreotide in a patient recovering from L-asparaginase-induced pancreatitis.
    Suzuki M; Takata O; Sakaguchi S; Fujimura J; Saito M; Shimizu T
    Exp Hematol; 2008 Mar; 36(3):253-4. PubMed ID: 18279714
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential administration of methotrexate and asparaginase in relapsed or refractory pediatric acute myeloid leukemia.
    Buaboonnam J; Cao X; Pauley JL; Pui CH; Ribeiro RC; Rubnitz JE; Inaba H
    Pediatr Blood Cancer; 2013 Jul; 60(7):1161-4. PubMed ID: 23335430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [State-of-the-art chemotherapy for acute myeloid leukemia].
    Miyawaki S
    Rinsho Ketsueki; 2012 Jan; 53(1):39-50. PubMed ID: 22374524
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous infiltration in acute promyelocytic leukemia.
    Ueda K; Kume A; Furukawa Y; Higashi N
    J Am Acad Dermatol; 1997 Jan; 36(1):104-6. PubMed ID: 8996272
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete remission of acute promyelocytic leukemia in a very elderly patient after treatment with low dose arsenic trioxide and sequential retinoic acid: a case report.
    Lin J; Zhu H; Li S; Fan H; Lu X
    Ann Hematol; 2014 Feb; 93(2):335-6. PubMed ID: 23719691
    [No Abstract]   [Full Text] [Related]  

  • 12. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
    Cervera J; Montesinos P; Hernández-Rivas JM; Calasanz MJ; Aventín A; Ferro MT; Luño E; Sánchez J; Vellenga E; Rayón C; Milone G; de la Serna J; Rivas C; González JD; Tormo M; Amutio E; González M; Brunet S; Lowenberg B; Sanz MA
    Haematologica; 2010 Mar; 95(3):424-31. PubMed ID: 19903674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy.
    Dvorak CC; Sanders RP; Dahl GV; Donaldson SS; Razzouk BI
    Pediatr Blood Cancer; 2007 May; 48(5):582-5. PubMed ID: 16123994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology Group.
    Liang DC; Hung IJ; Yang CP; Lin KH; Chen JS; Hsiao TC; Chang TT; Pui CH; Lee CH; Lin KS
    Leukemia; 1999 Feb; 13(2):155-60. PubMed ID: 10025887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukemia cutis in acute promyelocytic leukemia].
    del Río Garma J; Varela Gómez MR; Torres Carrete JP; Batlle Fonrodona FJ
    Sangre (Barc); 1997 Feb; 42(1):87-8. PubMed ID: 9229813
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid function during L-asparaginase therapy in children with acute lymphoblastic leukemia: difference between induction and late intensification.
    Ferster A; Glinoër D; Van Vliet G; Otten J
    Am J Pediatr Hematol Oncol; 1992 Aug; 14(3):192-6. PubMed ID: 1510186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Treatment Outcomes of Childhood Acute Promyelocytic Leukemia in Korea: A Nationwide Multicenter Retrospective Study by Korean Pediatric Oncology Study Group.
    Park KM; Yoo KH; Kim SK; Lee JW; Chung NG; Ju HY; Koo HH; Lyu CJ; Han SM; Han JW; Choi JY; Hong KT; Kang HJ; Shin HY; Im HJ; Koh KN; Kim H; Kook H; Baek HJ; Kim BR; Yang EJ; Lim JY; Park ES; Choi EJ; Park SK; Lee JM; Shim YJ; Kim JY; Park JK; Kong SG; Choi YB; Cho B; Lim YT
    Cancer Res Treat; 2022 Jan; 54(1):269-276. PubMed ID: 33887821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA.
    Petti MC; Mandelli F
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):10-5. PubMed ID: 2928805
    [No Abstract]   [Full Text] [Related]  

  • 19. Cuban experience in the treatment of acute promyelocytic leukemia with ALL transretinoic acid followed by intensive chemotherapy.
    Hernández P; Martinez G; Losada R; Machín S; Cayado N; Gramatges A
    Haematologica; 2002 Mar; 87(3):ELT14. PubMed ID: 11869960
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathological response of transitional cell carcinoma to arsenic trioxide during the treatment of concurrently diagnosed acute promyelocytic leukaemia.
    Krishna R; Sorour Y; Goepel JR; Kirkbride P; Smith DJ; Ezaydi Y; Dalley CD; Snowden JA
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):769-71. PubMed ID: 18995171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.